North America still accounts for 84% of all reported ATS laboratories in the world, and Western Europe has traditionally been a production center for synthetic drugs (particularly in the Czech Republic and the Netherlands). In the past few years, however, decreasing lab seizures in the US and the European Union have been offset by a rise in production in neighboring countries, like Canada and Mexico in North America, and Turkey in Southeast Europe.